Sk Bioscience Co Stock Net Income
| 302440 Stock | 47,850 650.00 1.34% |
SK Bioscience Co fundamentals help investors to digest information that contributes to SK Bioscience's financial success or failures. It also enables traders to predict the movement of 302440 Stock. The fundamental analysis module provides a way to measure SK Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SK Bioscience stock.
302440 |
SK Bioscience Co Company Net Income Analysis
SK Bioscience's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current SK Bioscience Net Income | 355.14 B |
Most of SK Bioscience's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SK Bioscience Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, SK Bioscience Co reported net income of 355.14 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The net income for all Republic of Korea stocks is significantly lower than that of the firm.
302440 Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SK Bioscience's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SK Bioscience could also be used in its relative valuation, which is a method of valuing SK Bioscience by comparing valuation metrics of similar companies.SK Bioscience is currently under evaluation in net income category among its peers.
302440 Fundamentals
| Return On Equity | 0.18 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.36 % | |||
| Operating Margin | 0.47 % | |||
| Current Valuation | 5.52 T | |||
| Shares Outstanding | 76.78 M | |||
| Shares Owned By Insiders | 69.27 % | |||
| Shares Owned By Institutions | 4.61 % | |||
| Price To Book | 4.01 X | |||
| Price To Sales | 8.39 X | |||
| Revenue | 929 B | |||
| Gross Profit | 570.03 B | |||
| EBITDA | 493.33 B | |||
| Net Income | 355.14 B | |||
| Total Debt | 35.5 B | |||
| Cash Flow From Operations | 536.59 B | |||
| Earnings Per Share | 917.26 X | |||
| Target Price | 82083.0 | |||
| Market Capitalization | 5.56 T | |||
| Total Asset | 2.11 T | |||
| Z Score | 93.6 | |||
| Net Asset | 2.11 T |
About SK Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SK Bioscience Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SK Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SK Bioscience Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with SK Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if SK Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SK Bioscience will appreciate offsetting losses from the drop in the long position's value.Moving together with 302440 Stock
Moving against 302440 Stock
The ability to find closely correlated positions to SK Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace SK Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back SK Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling SK Bioscience Co to buy it.
The correlation of SK Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as SK Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if SK Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for SK Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in 302440 Stock
SK Bioscience financial ratios help investors to determine whether 302440 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 302440 with respect to the benefits of owning SK Bioscience security.